Quantcast

Latest Urinary bladder Stories

2010-10-19 08:07:00

Fifth Most Frequently Diagnosed Cancer in U.S. Affects Approximately 70,000 Americans Each Year NEW YORK, Oct. 19 /PRNewswire-USNewswire/ -- Bladder cancer is the fifth most commonly diagnosed cancer in the United States, yet most people know nothing about it. To help enhance the public's understanding of the risks and signs of bladder cancer and the importance of early detection and treatment options, the Bladder Cancer Advocacy Network (BCAN) will hold its regional Bladder Cancer...

2010-09-29 12:34:39

Scientists may have discovered a way to diagnose bladder cancer at its earliest and, therefore, most treatable stages by measuring the presence or absence of microRNA using already available laboratory tests. "Measuring expressions of microRNA in bodily fluid represents a very promising tool with widespread implications for screening," said Liana Adam, M.D., Ph.D., assistant professor in urology at The University of Texas MD Anderson Cancer Center. Adam presented her findings at the Fourth...

2010-09-27 14:56:00

BELLEVILLE, ON, Sept. 27 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology driven Canadian biopharmaceutical company, has noted substantial share trading volume and share price increase over recent days. Management believes that this market activity is driven by expectation of a disclosure concerning its U.S. Food and Drug Administration (FDA) Phase III Fast Track clinical trial with Urocidin(TM) a product for non-muscle-invasive bladder cancer that...

2010-09-23 08:27:00

MINNEAPOLIS, Sept. 23 /PRNewswire/ -- Uroplasty, Inc. (Nasdaq: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results of a study "Percutaneous Tibial Nerve Stimulation Effects on Detrusor Overactivity Incontinence Are Not Due to a Placebo Effect: A Randomized, Double-Blind, Placebo Controlled Trial," to be published in the November 2010 print edition of THE JOURNAL OF...

2010-09-14 07:30:00

EAST NORRITON, Pa., Sept. 14 /PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, today announced that Steven Nichtberger, M.D., President and Chief Executive Officer of Tengion, will present at the upcoming UBS Global Life Sciences Conference on Monday, September 20, 2010, at 8:30am EDT. A live webcast of the presentation can be accessed under "Calendar of Events" in the Investors section of the Company's website at www.tengion.com. A replay of the...

2010-09-07 07:00:00

EAST NORRITON, Pa., Sept. 7 /PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, today announced that Steven Nichtberger, M.D., President and Chief Executive Officer of Tengion, will present at the upcoming Rodman & Renshaw 12th Annual Healthcare Conference on Monday, September 13, 2010, at 2:50pm EDT. A live webcast of the presentation can be accessed under "Calendar of Events" in the Investors section of the Company's website at www.tengion.com. A replay...

2010-08-18 18:16:27

A number of resarch studies at Baylor College of Medicine are seeking participants. These studies are important because they help doctors and researchers uncover the disease process and find potential treatment and cures. A list of BCM research studies can be found at www.bcm.edu/clinicalstudies/. Among the studies listed: Older men with smoking history needed for bladder cancer screening study Men over the age of 60 who have smoked for at least 20 years are being asked to participate in a...

2010-08-18 15:09:45

Bladder cancer has a high cure rate when caught early, but knowing the warning signs and risk factors for the disease is especially important because routine screenings are not common, said a Baylor College of Medicine urologic oncologist. "Bladder cancer is a highly treatable, highly curable disease particularly before it invades the muscle," said Dr. Seth P. Lerner, professor in the Scott Department of Urology and the NCI-designated Dan L. Duncan Cancer Center at BCM and Beth and Dave Swalm...

2010-08-02 07:00:00

EAST NORRITON, Pa., Aug. 2 /PRNewswire-FirstCall/ -- Tengion Inc. (Nasdaq: TNGN) today announced that it has appointed A. Brian Davis to the position of Chief Financial Officer. Mr. Davis comes to Tengion after 15 years with Neose Technologies, Inc., a biopharmaceutical company using enzymatic technologies to develop improved protein therapeutics. At its peak, Neose employed 200 individuals, including cGMP production, development and research personnel at three sites. "Brian's...

2010-07-19 12:53:39

Only study currently available did not collect data on important aspects and is susceptible to bias It is unclear whether patients with neurogenic bladder disorders benefit from the drug L-methionine. The only study currently available provides neither proof of benefit nor proof of harm. This is the result of a report published by the German Institute for Quality and Efficiency in Health Care (IQWiG) on 12 July 2010. The normal function of the bladder is to ensure the storage of urine and its...


Latest Urinary bladder Reference Libraries

Urinary Bladder
2013-01-18 10:29:10

The urinary bladder is a hollow organ that holds the urine, a fluid by-product excreted from the kidneys. Once enough urine is collected within the bladder, pressure initiates the process of urination which expels the urine from the system completely. Formation and Orientation Bladders are a common organ in the Animal Kingdom but are unique in characteristics to each species. Within the human species, there are some differences between female and male bladders. The first difference is...

More Articles (1 articles) »
Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related